Jove
Visualize
Contact Us

Related Experiment Videos

The prospects for AIDS vaccines.

W C Koff1

  • 1Division of AIDS, National Institute of Allergy and Infectious Diseases, Rockville, Md.

Hospital Practice (Office Ed.)
|April 15, 1991
PubMed
Summary

Researchers are exploring various human immunodeficiency virus (HIV) vaccine strategies in early trials. Key questions involve identifying immunogenic viral components and understanding protective immune responses for potential AIDS treatment and prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference.

Biologicals : journal of the International Association of Biological Standardization·2010
Same author

Replicating viral vectors as HIV vaccines Summary Report from IAVI Sponsored Satellite Symposium, International AIDS Society Conference, July 22, 2007.

Biologicals : journal of the International Association of Biological Standardization·2008
Same author

Evaluation of a lipopeptide immunogen as a therapeutic in HIV type 1-seropositive individuals.

AIDS research and human retroviruses·2000
Same author

Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex.

Proceedings of the National Academy of Sciences of the United States of America·1999
Same author

DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunity.

Vaccine·1997
Same author

International clinical trials of HIV vaccines: II. phase I trial of an HIV-1 synthetic peptide vaccine evaluating an accelerated immunization schedule in Yunnan, China.

Asian Pacific journal of allergy and immunology·1997
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Immunology
  • Vaccinology
  • Virology

Background:

  • Current human immunodeficiency virus (HIV) research focuses on developing effective vaccines.
  • Phase 1 clinical trials are investigating several novel vaccine strategies.
  • Identifying key immunogenic components of HIV is crucial for vaccine design.

Purpose of the Study:

  • To evaluate the immunogenicity of recombinant subunit preparations in HIV vaccine candidates.
  • To define the immune effectors and mediators responsible for protection against HIV.
  • To explore the potential of vaccines for both prevention and treatment of Acquired Immunodeficiency Syndrome (AIDS).

Main Methods:

  • Clinical trials involving recombinant subunit vaccine candidates.
  • Immunological assays to assess immune responses.
  • Analysis of viral components for immunogenicity.

Main Results:

  • Several HIV vaccine strategies are progressing through phase 1 clinical trials.
  • The immunogenicity of specific viral components is under investigation.
  • The precise immune mechanisms conferring protection against HIV remain to be fully elucidated.

Conclusions:

  • Ongoing research aims to identify optimal HIV vaccine targets.
  • Understanding protective immunity is essential for developing effective AIDS vaccines.
  • Vaccines hold promise for both preventing and treating HIV infection and AIDS.

Related Experiment Videos